Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Nystatin; triamcinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic sources for nystatin; triamcinolone acetonide and what is the scope of nystatin; triamcinolone acetonide patent protection?

Nystatin; triamcinolone acetonide
is the generic ingredient in seven branded drugs marketed by Glenmark Pharms Ltd, Savage Labs, Fougera Pharms Inc, Pharmaderm, Taro, Mylan Pharms Inc, Alpharma Us Pharms, Dr Reddys Labs Ltd, G And W Labs Inc, Teva, Pharmafair, Delcor Asset Corp, Perrigo New York, Perrigo Uk Finco, Riconpharma Llc, and Teligent Pharma Inc, and is included in twenty-eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for nystatin; triamcinolone acetonide. Fifteen suppliers are listed for this compound.

Summary for Generic Name: nystatin; triamcinolone acetonide

Drug Master File Entries: see list8
Suppliers / Packagers: see list15
Clinical Trials: see list118
Drug Prices:see low prices
DailyMed Link:nystatin; triamcinolone acetonide at DailyMed

Pharmacology for Ingredient: nystatin; triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs
nystatin; triamcinolone acetonide
CREAM;TOPICAL062597-001Oct 8, 1985DISCNNoNo► Subscribe► Subscribe
G And W Labs Inc
nystatin; triamcinolone acetonide
CREAM;TOPICAL062367-001May 28, 1985ATRXNoNo► Subscribe► Subscribe
nystatin; triamcinolone acetonide
CREAM;TOPICAL062596-001Oct 8, 1985DISCNNoNo► Subscribe► Subscribe
nystatin; triamcinolone acetonide
OINTMENT;TOPICAL062603-001Oct 9, 1985DISCNNoNo► Subscribe► Subscribe
Perrigo New York
nystatin; triamcinolone acetonide
OINTMENT;TOPICAL062280-002Oct 10, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus